Amer Bio Medica Financials

Amer Bio Stock Summary

Amer Bio competes with Atlantic American, and Accel Entertainment. American Bio Medica Corporation engages in manufacture and sale of lateral flow immunoassay tests primarily for the immediate detection of drugs in urine and oral fluids. American Bio Medica Corporation was incorporated in 1986 and is based in Kinderhook, New York. Amer Bio operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 32 people.

Amer Bio Key Financial Ratios

Amer Bio's financial ratios allow both analysts and investors to convert raw data from Amer Bio's financial statements into concise, actionable information that can be used to evaluate the performance of Amer Bio over time and compare it to other companies across industries.

Amer Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Amer Bio's current stock value. Our valuation model uses many indicators to compare Amer Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Amer Bio competition to find correlations between indicators driving Amer Bio's intrinsic value. More Info.Amer Bio Medica is number one stock in return on asset category among its peers. It also is number one stock in profit margin category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Amer Bio by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Amer Bio's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Amer Bio Market Pulse

Along with financial statement analysis, the daily predictive indicators of Amer Bio help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Amer Bio Medica. We use our internally-developed statistical techniques to arrive at the intrinsic value of Amer Bio Medica based on widely used predictive technical indicators. In general, we focus on analyzing Amer Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Amer Bio's daily price indicators and compare them against related drivers.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

If you are still planning to invest in Amer Bio Medica check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Amer Bio's history and understand the potential risks before investing.